COMBINATION THERAPIES OR STANDALONE INTERVENTIONS? INNOVATION OPTIONS FOR PHARMACEUTICAL FIRMS FIGHTING CANCER

Article OPEN
GUNJAN BHARDWAJ ; ANSHIT AGRAWAL ; RUPESH TYAGI (2015)
  • Journal: International Journal of Innovation Management, volume 19, issue 3, pages 1,540,003-1
  • Subject: Exploratory approach, exploitative approach, standalone, combination therapies, oncology, PD-1/PD-L1, network ecosystem

Innovation is key to the pharma model, from an initial discovery to the final development of a marketable drug. Here, we explore the innovation options in the fiercely contested therapeutic area of Oncology. We studied clinical development of drugs targeting PD-1 and PD... View more
Share - Bookmark